CS
DCPH

Credit Suisse’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Credit Suisse’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$566K Buy
35,958
+1,027
+3% +$15.8K ﹤0.01% 2582
2023
Q4 		$563K Sell
34,931
-7,979
-19% -$102K ﹤0.01% 2675
2023
Q3 		$546K Sell
42,910
-18,807
-30% -$259K ﹤0.01% 2634
2023
Q2 		$869K Buy
61,717
+12,954
+27% +$185K ﹤0.01% 2482
2023
Q1 		$753K Buy
48,763
+13,031
+36% +$218K ﹤0.01% 2491
2022
Q4 		$586K Buy
35,732
+159
+0.4% +$2.59K ﹤0.01% 2687
2022
Q3 		$658K Buy
35,573
+227
+0.6% +$3.56K ﹤0.01% 2623
2022
Q2 		$466K Sell
35,346
-1,227
-3% -$13.5K ﹤0.01% 2889
2022
Q1 		$339K Buy
36,573
+1,598
+5% +$13.6K ﹤0.01% 3168
2021
Q4 		$341K Buy
34,975
+404
+1% +$7.6K ﹤0.01% 4063
2021
Q3 		$1.18M Buy
34,571
+2,353
+7% +$75.1K ﹤0.01% 3208
2021
Q2 		$1.18M Buy
32,218
+3,267
+11% +$126K ﹤0.01% 3259
2021
Q1 		$1.3M Sell
28,951
-42,057
-59% -$1.96M ﹤0.01% 3139
2020
Q4 		$4.05M Buy
71,008
+9,124
+15% +$541K ﹤0.01% 2274
2020
Q3 		$3.17M Sell
61,884
-11,537
-16% -$565K ﹤0.01% 2094
2020
Q2 		$4.38M Buy
73,421
+53,045
+260% +$2.84M ﹤0.01% 1783
2020
Q1 		$839K Sell
20,376
-9,566
-32% -$531K ﹤0.01% 2797
2019
Q4 		$1.86M Buy
29,942
+15,635
+109% +$743K ﹤0.01% 2649
2019
Q3 		$486K Buy
+14,307
New +$424K ﹤0.01% 3459
2018
Q3 		– Sell
-5,863
Closed -$230K – 4045
2018
Q2 		$230K Buy
+5,863
New +$173K ﹤0.01% 3720

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Credit Suisse's DCPH Position: Q1 2024 in Review

Credit Suisse increased its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 2.9% in Q1 2024, buying an estimated $15.8K and bringing the position to 35,958 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #2582.

Credit Suisse first reported a position in DCPH in Q2 2018 and has held it in 20 quarters since. The position peaked at $4.38M in Q2 2020. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Credit Suisse held 35,958 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $566K as of Q1 2024.
  • Credit Suisse bought 1,027 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $15.8K.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2582 holding.
  • Credit Suisse first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and has held it in 20 quarters since.
  • Credit Suisse's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.38M in Q2 2020.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.